Literature DB >> 12428781

Negative mood, depressive symptoms, and major depression after smoking cessation treatment in smokers with a history of major depressive disorder.

Christopher W Kahler1, Richard A Brown, Susan E Ramsey, Raymond Niaura, David B Abrams, Michael G Goldstein, Timothy I Mueller, Ivan W Miller.   

Abstract

Negative mood, depressive symptoms, and major depressive episodes (MDEs) were examined in 179 smokers with a history of major depression in a trial comparing standard smoking cessation treatment to treatment incorporating cognitive-behavioral therapy for depression (CBT-D). Early lapses were associated with relatively large increases in negative mood on quit date. Mood improved in the 2 weeks after quit date among those returning to regular smoking but not among those smoking moderately. Continuous abstinence was associated with short- and long-term reductions in depressive symptoms. MDE incidence during follow-up was 15.3% and was not associated with abstinence. Unexpected was that CBT-D was associated with greater negative mood and depressive symptoms and increased MDE risk. Results suggest complex bidirectional associations between affect and smoking outcomes.

Entities:  

Mesh:

Year:  2002        PMID: 12428781     DOI: 10.1037//0021-843x.111.4.670

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  51 in total

Review 1.  Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity.

Authors:  Adam M Leventhal; Michael J Zvolensky
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

2.  Cigarette smoking and mood disorders in U.S. adolescents: sex-specific associations with symptoms, diagnoses, impairment and health services use.

Authors:  Amanda Richardson; Jian-Ping He; Laurel Curry; Kathleen Merikangas
Journal:  J Psychosom Res       Date:  2012-02-18       Impact factor: 3.006

3.  Positive Psychotherapy for Smoking Cessation: Treatment Development, Feasibility and Preliminary Results.

Authors:  Christopher W Kahler; Nichea S Spillane; Anne Day; Elise Clerkin; Acacia Parks; Adam M Leventhal; Richard A Brown
Journal:  J Posit Psychol       Date:  2014-01-01

4.  Negative affect as a mediator of the relationship between vigorous-intensity exercise and smoking.

Authors:  Candyce D Tart; Teresa M Leyro; Ashley Richter; Michael J Zvolensky; David Rosenfield; Jasper A J Smits
Journal:  Addict Behav       Date:  2010-02-01       Impact factor: 3.913

5.  The impact of quitting smoking on depressive symptoms: findings from the International Tobacco Control Four-Country Survey.

Authors:  Jae Cooper; Ron Borland; Hua-Hie Yong; Omid Fotuhi
Journal:  Addiction       Date:  2016-04-15       Impact factor: 6.526

6.  Positive Psychotherapy for Smoking Cessation: A Pilot Randomized Controlled Trial.

Authors:  Christopher W Kahler; Nichea S Spillane; Anne M Day; Patricia A Cioe; Acacia Parks; Adam M Leventhal; Richard A Brown
Journal:  Nicotine Tob Res       Date:  2015-02-02       Impact factor: 4.244

7.  Acute Effects of Aerobic Exercise on Affect and Smoking Craving in the Weeks Before and After a Cessation Attempt.

Authors:  Ana M Abrantes; Samantha G Farris; Haruka Minami; David R Strong; Deborah Riebe; Richard A Brown
Journal:  Nicotine Tob Res       Date:  2018-04-02       Impact factor: 4.244

8.  Smoking processes, panic, and depressive symptoms among treatment-seeking smokers.

Authors:  Dawn W Foster; Kirsten J Langdon; Norman B Schmidt; Michael Zvolensky
Journal:  Subst Use Misuse       Date:  2014-12-15       Impact factor: 2.164

9.  Hostility and smoking cessation treatment outcome in heavy social drinkers.

Authors:  Christopher W Kahler; Nichea S Spillane; Adam M Leventhal; David R Strong; Richard A Brown; Peter M Monti
Journal:  Psychol Addict Behav       Date:  2009-03

10.  Hostility, cigarette smoking, and responses to a lab-based social stressor.

Authors:  Christopher W Kahler; Adam M Leventhal; Suzanne M Colby; Chad J Gwaltney; Thomas W Kamarck; Peter M Monti
Journal:  Exp Clin Psychopharmacol       Date:  2009-12       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.